---
title: "bispecific_antibodies_for_relapse_and_refractory_multiple_myeloma"
date: "2024-08-24"
tags:
  - building
---

> [!NOTE]
> ðŸŒ± created from: [[multiple myeloma (MM)]]

# bispecific_antibodies_for_relapse_and_refractory_multiple_myeloma

[[bite_rrmm]]

- Triple Class and Penta Refracotry MM: Poor outcomes in relapse and refractory MM
- MAMMOTH study
- Current BsAb options in MM are:
  - BCMA, GPRC5D
  - [[majestec-1.md|MajesTEC-1]]
  - [[magnetismm-3.md|MagnetisMM-3]]
